Surprisingly, genes that displayed abrupt variations in non-GVHD samples in the CDP analysis (CTSS, TXNIP, OAZ1, and RPS12) also clearly distinguished the GVHD clinical course, either by a different form of fluctuation or by their abundance (Figure 4A left panels). This evidence concerns the gene OAZ1 and graft versus host disease.